Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-weekly darbepoetin alfa for prophylaxis of anemia in elderly cancer patients
2005-003701-91Phase 3Terminated
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Apr 2007
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of darbepoetin alfa in anemia (CIA), gastrointestinal cancer and bronchial carcinoma, sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Apr 2007; status: terminated.
02
Drugs
darbepoetin alfa
03
Conditions
anemia (CIA)gastrointestinal cancerbronchial carcinoma
Beyond the preview
Go deeper on 2005-003701-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003701-91.